However, we could not observe any association between the nuclear SMAD4 expression and higher nucleolar grade, tumor stage, and other clinicopathological findings in RCC samples, which is in line with the previous study by Cardillo et al. This evidence concerns the gene SMAD4 and renal cell carcinoma.